Join Don Jones, global expert on wireless technologies and mobility, and David Turner, President & CTO, Founder of Parallel 6 for what will be an informative and engaging webinar on how technology can enable you to run a large registry study for half the cost. We will cover how a scalable platform enables BYOD, as well as strategies to engage your patients over multiple years, and recruiting fast and furious.
Fully optimizing the clinical trials process requires practices and tools that streamline operations, automate processes, increase visibility and improve collaboration with sponsors, CROs, sites, regulators and review boards. The entire clinical ecosystem needs an overhaul and today pharmaceutical companies have access to a variety of cloud-based technologies that can radically improve the clinical trials process — but which tool to use and when? The webinar will focus on study startup as it relates to the overall picture of clinical study management and the opportunities and challenges associated with implementations in the eClinical stack.
New therapeutic products require new technologies, capabilities, resources and a thorough understanding of how temperature impacts preclinical and clinical studies and commercialization of regenerative medicines.
Learn how a current clinical study is leveraging disruptive mHealth technologies to ensure that collecting study data is accurate, seamless, and convenient.
There has been a strong focus on study conduct, but as stakeholders are increasingly aware that better SSU processes are linked to shorter clinical timelines, the emphasis is shifting in that direction.
The webinar will focus on study startup and discuss site selection practices from both the site and the Sponsor/CRO perspective.
Informed consent has a major impact on regulatory compliance, enrollment rates and expenses across the life of your study. Yet the traditional paper-based process has transformed informed consent into one of the most cited deficiencies.
This webinar will address common collaboration obstacles from both the CRO perspective and the sponsor perspective with a focus on increasing the value of strategic partnerships.
The industry's shift from paper to electronic Clinical Outcome Assessments (eCOA) in clinical trials is happening at dizzying speeds.
Learn about mobile innovation for virtual, hybrid, and site-based clinical trials using the Clinical Reach™ mClinical™ platform for patient enrollment, engagement, and management on a global scale. Followed by an in-depth Q&A session and Parallel 6 Chief Medical Officer, Brad Pruitt, M.D., MBA, who demonstrates the newly released mobile data monitoring solution which is designed to empower clinical research associates (CRAs).
|
|
|
|
|
|
|
|
|